Increasing COVID-19 testing and vaccination among Spanish speakers in the USA : protocol for the development and evaluation of the Nuestra Comunidad Saludable intervention using a group-randomised trial design

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ..

INTRODUCTION: Our community-based participatory research partnership aims to expand understanding of the social, ethical and behavioural implications of COVID-19 testing and vaccination to inform the development of an integrated intervention that harnesses community-based peer navigation and mHealth strategies to improve COVID-19 testing and vaccination; test the intervention; and develop and disseminate practice, research and policy recommendations to further increase COVID-19 testing and vaccination among Spanish-speaking Latine communities in the USA.

METHODS AND ANALYSIS: We will conduct 50 individual in-depth interviews with health providers, who have conducted COVID-19 testing and/or vaccination activities within Spanish-speaking communities, and with representatives from Latine-serving community-based organisations. We will also conduct six focus groups with 8-12 Spanish-speaking Latine community member participants each for a total number of about 60 focus group participants. Next, we will develop the Nuestra Comunidad Saludable intervention based on findings from interviews and focus groups and use a longitudinal group-randomised trial design with two arms (intervention and delayed intervention) to evaluate the impact of the intervention. We will recruit, enrol and collect baseline data from 20 community-based peer navigators (Navegantes) and their social network members (n=8 unique social network members per Navegante). Navegantes (coupled with their social networks) will be randomised to intervention or delayed intervention groups (10 Navegantes and 80 social network members per group).

ETHICS AND DISSEMINATION: Ethical approval for data collection was granted by the Wake Forest University School of Medicine Institutional Review Board. Following the description of study procedures, we will obtain consent from all study participants. Study findings will be disseminated through an empowerment theory-based community forum, peer-reviewed publications and presentations at scientific meetings, and reports and briefs for lay, community and practitioner audiences.

TRIAL REGISTRATION NUMBER: NCT05302908.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:12

Enthalten in:

BMJ open - 12(2022), 11 vom: 16. Nov., Seite e066585

Sprache:

Englisch

Beteiligte Personen:

Rhodes, Scott D [VerfasserIn]
Tanner, Amanda E [VerfasserIn]
Mann-Jackson, Lilli [VerfasserIn]
Alonzo, Jorge [VerfasserIn]
Hall, Mark A [VerfasserIn]
Bertoni, Alain G [VerfasserIn]
McCoy, Thomas P [VerfasserIn]
Aguilar-Palma, Sandy K [VerfasserIn]
Garcia, Manuel [VerfasserIn]
Miranda, Daniela [VerfasserIn]
Turner, Mari Jo [VerfasserIn]

Links:

Volltext

Themen:

COVID-19
Clinical Trial Protocol
EPIDEMIOLOGY
Journal Article
PREVENTIVE MEDICINE
PRIMARY CARE
PUBLIC HEALTH
QUALITATIVE RESEARCH
Research Support, N.I.H., Extramural

Anmerkungen:

Date Completed 21.11.2022

Date Revised 15.04.2023

published: Electronic

ClinicalTrials.gov: NCT05302908

Citation Status MEDLINE

doi:

10.1136/bmjopen-2022-066585

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM348983840